Explore top Series 65 exam prep courses to boost your career as an investment advisor. Access engaging materials and expert ...

Are GLP-1 weight loss drugs like Ozempic the miracle many have waited for, or are used guinea pigs in an experiment they’ll regret in a decade? That’s the central question of a discussion Wednesday on ...

A version of this article first appeared in CNBC's Healthy Returns newsletter, which brings the latest health-care news straight to your inbox. Subscribe here to receive future editions. GLP-1s are ...

Investigator-assessed PFS improved with atirmociclib plus fulvestrant versus fulvestrant alone or everolimus/exemestane, achieving HR 0.60 and meeting the primary endpoint with clinically meaningful ...

The miracle of rapid weight loss has always come with fine print. Until recently, it read mostly like a list of digestive complaints — stomachaches, constipation — generally unpleasant but tolerable ...

A class of medications best known for treating diabetes and obesity may also reduce the risk of addiction – and help people who already have one, a new study shows. Semaglutide (also known as Ozempic) ...

A patient of mine, a veteran who had tried to quit smoking for over a decade, told me that after he started a GLP-1 drug for his diabetes, he lost interest in cigarettes. He didn’t use a patch. He ...

GLP-1 drugs reduced substance use disorders in patients with type 2 diabetes. GLP-1 users had lower odds of new disorders or adverse outcomes of existing disorders. Effect was seen across broad range ...

In a recent review, a small group of patients received the injections less frequently but still maintained weight loss and health benefits. By Roni Caryn Rabin The doctor kept hearing the same story ...

For more than 30 years, the solar industry has been built around rectangular panels. Everything, from cutting the silicon cells to framing, shipping, mounting, and connecting them to inverters, has ...

A commentary by FDA officials Vinay Prasad, MD, MPH, and Martin Makary, MD, MPH, details the new system for drug approvals in the US. FDA Commissioner Martin Makary, MD, MPH, and his top deputy Vinay ...